Illumina
Foreign stocks
Investors in Thailand can buy ILMN through 8 mutual funds open to retail investors. Most of them (8 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds ILMN.
| Fund | ILMN weight | How it invests | 1-year return |
|---|---|---|---|
 K-CHANGE-A(A)K Positive Change Equity Fund | 5.63% | Via Baillie Gifford Positive Change Fund | −1.68% |
| K-CHANGERMFK Positive Change Equity RMF | 5.62% | Via Baillie Gifford Positive Change Fund | −1.73% |
 ES-GENOMEEastspring Genomic Revolution Fund | 4.71% | Via several master funds (ARK Genomic Revolution UCITS, ARK Genomic Revolution, iShares Genomics Immunology and Healthcare) | +56.72% |
 TGENOMETISCO Genomic Revolution Fund | 3.80% | Via several master funds (ARK Genomic Revolution, iShares Genomics Immunology and Healthcare, ISHARES BIOTECHNOLOGY) | +54.22% |
 SCBGENOME(A)SCB Genomic Revolution | 3.60% | Via several master funds (ARK Genomic Revolution, iShares Genomics Immunology and Healthcare) | +61.33% |
 DAOL-GSECUREDAOL GLOBAL SECURITY EQUITY FUND | 3.13% | Via CS Investment Funds 2-UBS (Lux) Security Equity Fund | +11.72% |
 KT-USSM-AKTAM US Small Cap Equity Passive Fund | 0.51% | Via VB | +12.60% |
 KKP EWUS500-UHKKP US500 EQUAL WEIGHT FUND - UNHEDGED | 0.27% | Via RSP | +22.16% |
| Period | SMA | EMA | Price vs line |
|---|---|---|---|
| 10 days | 259.55 | 252.20 | Below |
| 20 days | 265.09 | 258.47 | Below |
| 50 days | 249.77 | 248.21 | Below |
| 100 days | 219.87 | 224.34 | Above |
| 200 days | 177.39 | 192.33 | Above |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 37.86 | Down |
| MACD(12,26) | −3.50 | Down |
| ADX(14) | 37.23 | Neutral |
| ATR(14) % of price | 4.38 | Neutral |
No financial statements for ILMN in the system yet — the share price above is the actual daily close
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
KASSET2EASTSPRING1TISCOASSET1SCBAM1DAOLINV1KTAM1KKPAM1| Fund | ILMN weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| K-CHANGE-A(A) | 5.63% | Baillie Gifford Positive Change Fund | −1.68% | 1.43% |
| K-CHANGERMF | 5.62% | Baillie Gifford Positive Change Fund | −1.73% | 1.42% |
| ES-GENOME | 4.71% | several master funds (ARK Genomic Revolution UCITS, ARK Genomic Revolution, iShares Genomics Immunology and Healthcare) | +56.72% | 1.25% |
| TGENOME | 3.80% | several master funds (ARK Genomic Revolution, iShares Genomics Immunology and Healthcare, ISHARES BIOTECHNOLOGY) | +54.22% | 1.28% |
| SCBGENOME(A) | 3.60% | several master funds (ARK Genomic Revolution, iShares Genomics Immunology and Healthcare) | +61.33% | 0.62% |
| DAOL-GSECURE | 3.13% | CS Investment Funds 2-UBS (Lux) Security Equity Fund | +11.72% | 2.14% |
| KT-USSM-A | 0.51% | VB | +12.60% | 1.08% |
| KKP EWUS500-UH | 0.27% | RSP | +22.16% | 1.20% |
| Master fund | Thai funds using this route | Master fund's ILMN weight |
|---|---|---|
| Baillie Gifford Positive Change Fund | 2 | 5.63% |
| several master funds (ARK Genomic Revolution UCITS, ARK Genomic Revolution, iShares Genomics Immunology and Healthcare) | 1 | 4.71% |
| several master funds (ARK Genomic Revolution, iShares Genomics Immunology and Healthcare, ISHARES BIOTECHNOLOGY) | 1 | 3.80% |
| several master funds (ARK Genomic Revolution, iShares Genomics Immunology and Healthcare) | 1 | 3.60% |
| CS Investment Funds 2-UBS (Lux) Security Equity Fund | 1 | 3.13% |
| Vanguard Morningstar Small-Cap ETF | 1 | 0.51% |
| Invesco S&P 500 Equal Weight ETF | 1 | 0.27% |
